Board reviews LD 1803 stakeholder feedback on access, scope and PMP implications
The board reviewed its first stakeholder meeting on LD 1803, focusing on geographic distribution of optometrists and ophthalmologists, cited safety data from states with expanded scope, and discussed whether opioid-prescribing rules and the state PMP should be addressed in board regulations.
The full story
At its Oct. 3 meeting the board reviewed the initial stakeholder meeting for LD 1803, which centered on access to eye care across Maine and the distribution of optometrists and ophthalmologists statewide. Members discussed national comparisons and “compelling safety data from states with scope expansion,” and agreed to divide tasks for follow-up work.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
Keep reading for free
Create a free account to finish this story and see the video, transcript and key details.
Continue with GoogleContinue with emailAlready have an account? Log in